Sectra AB (publ) (SECT-B.ST)
SEK 263.2
(3.3%)
SEK 263.2
(3.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 557.55 Million SEK | -73.99% |
| 2022 | 2.14 Billion SEK | 25.54% |
| 2021 | 1.7 Billion SEK | 15.08% |
| 2020 | 1.48 Billion SEK | 2.0% |
| 2019 | 1.45 Billion SEK | 21.59% |
| 2018 | 1.19 Billion SEK | 8.08% |
| 2017 | 1.1 Billion SEK | 10.26% |
| 2016 | 1 Billion SEK | 5.28% |
| 2015 | 953.59 Million SEK | 13.37% |
| 2014 | 841.11 Million SEK | 12.05% |
| 2013 | 750.65 Million SEK | 6.88% |
| 2012 | 702.33 Million SEK | 4.0% |
| 2011 | 675.29 Million SEK | -25.86% |
| 2010 | 910.88 Million SEK | 5.37% |
| 2009 | 864.5 Million SEK | 33.1% |
| 2008 | 649.52 Million SEK | 3.96% |
| 2007 | 624.77 Million SEK | 430.23% |
| 2006 | 117.83 Million SEK | 23.5% |
| 2005 | 95.41 Million SEK | -75.26% |
| 2004 | 385.63 Million SEK | 0.53% |
| 2003 | 383.61 Million SEK | 12.65% |
| 2002 | 340.52 Million SEK | 34.31% |
| 2001 | 253.53 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 108.08 Million SEK | 198.24% |
| 2023 Q4 | 212.4 Million SEK | 152.47% |
| 2023 Q3 | 84.12 Million SEK | -87.59% |
| 2023 Q1 | 530.63 Million SEK | -16.97% |
| 2023 FY | 557.55 Million SEK | -73.99% |
| 2023 Q2 | 677.71 Million SEK | 27.72% |
| 2022 Q1 | 447.39 Million SEK | -15.85% |
| 2022 Q3 | 541.34 Million SEK | 4.98% |
| 2022 FY | 2.14 Billion SEK | 25.54% |
| 2022 Q2 | 515.66 Million SEK | 15.26% |
| 2022 Q4 | 639.11 Million SEK | 18.06% |
| 2021 Q4 | 531.66 Million SEK | 27.7% |
| 2021 Q1 | 371.44 Million SEK | -24.17% |
| 2021 FY | 1.7 Billion SEK | 15.08% |
| 2021 Q2 | 387.91 Million SEK | 4.43% |
| 2021 Q3 | 416.33 Million SEK | 7.33% |
| 2020 Q2 | 367.13 Million SEK | 35.32% |
| 2020 Q1 | 271.31 Million SEK | -40.66% |
| 2020 Q3 | 355.34 Million SEK | -3.21% |
| 2020 Q4 | 489.84 Million SEK | 37.85% |
| 2020 FY | 1.48 Billion SEK | 2.0% |
| 2019 FY | 1.45 Billion SEK | 21.59% |
| 2019 Q1 | 291.53 Million SEK | -13.11% |
| 2019 Q2 | 316.64 Million SEK | 8.61% |
| 2019 Q3 | 389.19 Million SEK | 22.91% |
| 2019 Q4 | 457.22 Million SEK | 17.48% |
| 2018 Q1 | 268.81 Million SEK | -17.57% |
| 2018 FY | 1.19 Billion SEK | 8.08% |
| 2018 Q4 | 335.51 Million SEK | 10.09% |
| 2018 Q3 | 304.75 Million SEK | 6.09% |
| 2018 Q2 | 287.24 Million SEK | 6.86% |
| 2017 Q3 | 276.38 Million SEK | 2.07% |
| 2017 Q4 | 326.11 Million SEK | 17.99% |
| 2017 Q1 | 233.66 Million SEK | -21.79% |
| 2017 Q2 | 270.77 Million SEK | 15.88% |
| 2017 FY | 1.1 Billion SEK | 10.26% |
| 2016 Q1 | 205.78 Million SEK | -24.14% |
| 2016 Q3 | 257.69 Million SEK | 6.61% |
| 2016 Q4 | 298.74 Million SEK | 15.93% |
| 2016 Q2 | 241.72 Million SEK | 17.47% |
| 2016 FY | 1 Billion SEK | 5.28% |
| 2015 Q1 | 209.56 Million SEK | -13.95% |
| 2015 FY | 953.59 Million SEK | 13.37% |
| 2015 Q4 | 271.28 Million SEK | 8.03% |
| 2015 Q2 | 221.63 Million SEK | 5.76% |
| 2015 Q3 | 251.11 Million SEK | 13.31% |
| 2014 FY | 841.11 Million SEK | 12.05% |
| 2014 Q1 | 188.97 Million SEK | -19.3% |
| 2014 Q2 | 198.76 Million SEK | 5.18% |
| 2014 Q4 | 243.54 Million SEK | 16.07% |
| 2014 Q3 | 209.83 Million SEK | 5.57% |
| 2013 Q4 | 234.15 Million SEK | 25.08% |
| 2013 Q3 | 187.2 Million SEK | 6.11% |
| 2013 Q1 | 152.87 Million SEK | -22.39% |
| 2013 Q2 | 176.42 Million SEK | 15.4% |
| 2013 FY | 750.65 Million SEK | 6.88% |
| 2012 Q2 | 168.69 Million SEK | 9.76% |
| 2012 Q1 | 153.68 Million SEK | -48.46% |
| 2012 FY | 702.33 Million SEK | 4.0% |
| 2012 Q4 | 196.98 Million SEK | 7.66% |
| 2012 Q3 | 182.97 Million SEK | 8.47% |
| 2011 Q2 | 185.24 Million SEK | 33.84% |
| 2011 Q3 | 117.12 Million SEK | -36.77% |
| 2011 Q4 | 298.16 Million SEK | 154.57% |
| 2011 FY | 675.29 Million SEK | -25.86% |
| 2011 Q1 | 138.41 Million SEK | -34.54% |
| 2010 Q1 | 211.02 Million SEK | -17.97% |
| 2010 Q3 | 236.18 Million SEK | -6.36% |
| 2010 FY | 910.88 Million SEK | 5.37% |
| 2010 Q4 | 211.43 Million SEK | -10.48% |
| 2010 Q2 | 252.24 Million SEK | 19.53% |
| 2009 Q4 | 257.25 Million SEK | 25.57% |
| 2009 FY | 864.5 Million SEK | 33.1% |
| 2009 Q1 | 202.49 Million SEK | 0.0% |
| 2009 Q2 | 199.89 Million SEK | -1.28% |
| 2009 Q3 | 204.86 Million SEK | 2.49% |
| 2008 FY | 649.52 Million SEK | 3.96% |
| 2007 FY | 624.77 Million SEK | 430.23% |
| 2006 FY | 117.83 Million SEK | 23.5% |
| 2005 FY | 95.41 Million SEK | -75.26% |
| 2004 FY | 385.63 Million SEK | 0.53% |
| 2003 FY | 383.61 Million SEK | 12.65% |
| 2002 FY | 340.52 Million SEK | 34.31% |
| 2001 FY | 253.53 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -10425.845% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -85.48% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -85.48% |
| Arcoma AB | 11.07 Million SEK | -4936.167% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | -298.307% |
| BICO Group AB (publ) | 1.83 Billion SEK | 69.543% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | -123.277% |
| CellaVision AB (publ) | 463.04 Million SEK | -20.411% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -18503.737% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 2062.245% |
| C-Rad AB (publ) | 66.01 Million SEK | -744.587% |
| Duearity AB (publ) | -4.17 Million SEK | 13444.998% |
| Dignitana AB (publ) | 58.97 Million SEK | -845.472% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 1433.861% |
| Getinge AB (publ) | 13.43 Billion SEK | 95.849% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 1210.282% |
| Iconovo AB (publ) | 17.57 Million SEK | -3071.948% |
| Integrum AB (publ) | 690.56 Thousand SEK | -80639.166% |
| Luxbright AB (publ) | -2.79 Million SEK | 20034.884% |
| Mentice AB (publ) | 236.38 Million SEK | -135.871% |
| OssDsign AB (publ) | 83.64 Million SEK | -566.572% |
| Paxman AB (publ) | 12.61 Million SEK | -4318.719% |
| Promimic AB (publ) | 38.51 Million SEK | -1347.628% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 1198.564% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -3376.673% |
| ScandiDos AB (publ) | 47.55 Million SEK | -1072.44% |
| Sedana Medical AB (publ) | 108.98 Million SEK | -411.607% |
| Senzime AB (publ) | 8.33 Million SEK | -6586.101% |
| SpectraCure AB (publ) | -9.22 Million SEK | 6145.256% |
| Stille AB | 132.17 Million SEK | -321.843% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 71.812% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | -33.734% |